Skip to main content

NATCO 30 Pill - blue & pink capsule/oblong

Pill with imprint NATCO 30 is Blue & Pink, Capsule/Oblong and has been identified as Lansoprazole Delayed-Release 30 mg. It is supplied by Breckenridge Pharmaceutical, Inc.

Lansoprazole is used in the treatment of Barrett's Esophagus; GERD; Duodenal Ulcer; Duodenal Ulcer Prophylaxis; Erosive Esophagitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NATCO 30

Lansoprazole delayed-release 30 mg NATCO 30
Lansoprazole delayed-release 30 mg NATCO 30
Lansoprazole delayed-release 30 mg NATCO 30
Lansoprazole delayed-release 30 mg NATCO 30

Lansoprazole Delayed-Release

Imprint
NATCO 30
Strength
30 mg
Color
Blue & Pink
Shape
Capsule/Oblong
Availability
Rx and/or OTC
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Breckenridge Pharmaceutical, Inc.
Inactive Ingredients
acetone, isopropyl alcohol, magnesium carbonate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polyethylene glycol 4000, polysorbate 80, sucrose, corn starch, magnesium silicate, titanium dioxide, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40, water, ammonia, potassium hydroxide, propylene glycol, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
45963-0461 (Discontinued) Actavis Pharma, Inc.
51991-0772 (Discontinued) Breckenridge Pharmaceutical, Inc.

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.